Ilumed, a Medicare transformation company focused on assisting patients to achieve their healthiest lives by driving lower-cost, better-quality and more-equitable healthcare outcomes, today announced it has closed a $16.5 million Series A financing led by Ascend Partners. The company’s angel investor was WRJM Healthcare Partners, LLC, whose principals are Ron Kuerbitz, Joshua Ruskin, Bill Sanger and Matthew Sanger.

Ilumed is one of fifty-three (53) Direct Contracting Entities (DCE) approved by the Centers for Medicare & Medicaid Services (CMS) as part of CMS’s Global and Professional Direct Contracting (GPDC) Model, which was designed to enhance care-quality for Medicare fee-for-service beneficiaries while simultaneously reducing costs through risk-sharing arrangements with physicians.

Ilumed Raises $16.5 Million Series A Financing

Description

Company Information

Funding Insights

Ilumed Raises $16.5 Million Series A Financing

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information